KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Total Non-Current Liabilities (2018 - 2024)

BioNTech SE's Total Non-Current Liabilities history spans 7 years, with the latest figure at $636.2 million for Q4 2024.

  • For Q4 2024, Total Non-Current Liabilities fell 14.29% year-over-year to $636.2 million; the TTM value through Dec 2024 reached $636.2 million, down 14.29%, while the annual FY2024 figure was $644.4 million, 13.65% down from the prior year.
  • Total Non-Current Liabilities for Q4 2024 was $636.2 million at BioNTech SE, down from $742.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $742.3 million in Q4 2023 and bottomed at $278.4 million in Q4 2022.
  • The 5-year median for Total Non-Current Liabilities is $521.1 million (2021), against an average of $516.9 million.
  • The largest annual shift saw Total Non-Current Liabilities plummeted 46.57% in 2022 before it soared 166.6% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $406.3 million in 2020, then increased by 28.24% to $521.1 million in 2021, then tumbled by 46.57% to $278.4 million in 2022, then soared by 166.6% to $742.3 million in 2023, then dropped by 14.29% to $636.2 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Total Non-Current Liabilities are $636.2 million (Q4 2024), $742.3 million (Q4 2023), and $278.4 million (Q4 2022).